Ehlers Danlos syndrome is genetic disorders that affect the body's connective tissue, which causes an unusually large range of movement or overextension in a patient's joints, which can lead to frequent dislocations, chronic pain, and early onset of arthritis. The disorder also causes the skin to become fragile and stretchy, making it bruise easily and interfering with the skin's healing process. When the syndrome affects the vascular system, it can cause internal bleeding which is potentially life threatening. Symptoms of the disorder include severe muscle, abdominal, or neuropathic pain, which interferes with one's daily life. The disorder can also produce migraines and fatigue.
Because cannabis has analgesic properties, it can help patients who suffer from Ehlers Danlos syndrome manage their pain symptoms. Cannabis significantly lowers pain levels, even when other treatments have proven ineffective. Current studies have shown that opioid medications have proven the most effective in managing the pain of Ehlers Danlos syndrome. While cannabis has not been included in these particular studies, multiple studies have found that patients find cannabis not only as effective as opioid medications, but also preferable to the medications due to their limited side effects and the impossibility of leading to a fatal overdose. Because of this, it is highly plausible that cannabis would be an effective treatment option in managing Ehlers Danlos pain, and patients might prefer substituting medical marijuana for their current medication regimen. We hope to see clinical studies in the future that investigate the use of cannabis for Ehlers Danlos syndrome.
This information has been brought to you by Medical Marijuana Inc. and approved by our Chief Medical Officer.